Selling into health systems means a long committee, a high evidence bar, and a review process that strips content of everything interesting. We build authority that clears review and still earns a clinical audience.
Certified LinkedIn Marketing Partner · Thought Leader of the Year, LinkedIn 2026
Free, back in 48 hours. No sales call to get it.
A physician or clinical informaticist can tell within a sentence whether the person writing has ever been in a hospital. Generic content doesn't just fail here, it actively costs credibility.
Every asset goes into a queue and returns with the specifics gone. What publishes is safe, vague, and unreadable, so the team stops investing in it.
Clinical leadership, IT and informatics, compliance and privacy, finance, and procurement. Any one of them can stall it, and reaching all of them repeatedly across a cycle this long is beyond what outbound can economically do.
Patient-centered, improving outcomes, interoperable, AI-powered. It's the whole category, and to a clinical buyer it reads as noise rather than evidence.
Patient-centered, improving outcomes, seamless interoperability, AI-powered. Interchangeable across every vendor at every conference, which pushes buyers back to whoever their peer institution already uses.
The mechanism explained properly, the evidence stated carefully, and a real position on where reimbursement, regulation and clinical workflow are heading. Specificity is more persuasive to a clinician and, done right, easier to defend in review than a broad outcome claim.
We map what competing vendors claim and where the category over-promises, then build pillars around what you can actually substantiate, in language your reviewers can approve.
The CMO, CMIO, or service-line chief. They decide whether this belongs anywhere near care delivery. They are persuaded by mechanism, evidence, and peers, and by almost nothing else.
Integration, workflow, and data. They've been burned by systems that promised interoperability. Published technical substance is what earns them early.
Gatekeeper. Anything touching patient data goes through them. Careful, informed public thinking on how you handle data reduces friction before their review begins.
They need the operational and financial case, and increasingly the reimbursement implications, in numbers rather than narrative.
Usually one physician or nurse leader who advocates internally. They need something rigorous and forwardable. Arming that person well is often the entire difference in a health-system deal.
Monthly sessions with your clinical lead, medical director, or clinically-credentialed founder. Their credibility is the asset, and it can't be substituted with marketing writing.
The piece that fixes velocity. We work with your compliance, legal and medical reviewers once, up front, to establish what can be said and how it must be framed, then every asset is written inside those boundaries. Review becomes a check rather than a rewrite.
How the thing works, what the evidence supports, and where the limits are. Careful framing is both more defensible and more persuasive to a clinical reader than a broad claim.
How clinical and operational leaders describe the problem, pulled from your calls, so content reads like their workflow rather than your product.
Existing health-system clients (expansion across service lines is usually the fastest revenue in this pocket), CRM, conference and symposium attendees, and site visitors. Warm first-party audiences convert in the $75-150 range across the accounts we manage, against $300-600+ cold.
We build the target list from real signal and give clinical leadership, informatics, compliance and finance each their own message, so your clinical champion isn't carrying the entire internal case alone.
Health-system evaluations run long enough that affordability matters more than reach. Amplifying proven organic content is how you stay present for months rather than weeks.
Organic engagers, named site visitors and ad engagers flow into one account view, so you can see which systems are quietly evaluating. Multi-touch accounts convert to pipeline at 3x+ single-touch across the accounts we manage.
Real expertise goes in. A governed knowledge base holds your voice, positioning and proof, and the five foundational documents that run it. Sharp, on-brand assets come out, everywhere.
We get to know your brand, offering and competitor landscape, find the gaps and where your UVP wins, land your core messaging pillars, then map the messaging to your audiences and funnel stages. Nine milestones, three phases, about 4 to 6 weeks. Shared ownership: when a step slips, every downstream step shifts with it.
Notes, voice memos, a short prompt or guide, or pillar questions.
A full month built in your voice, ready to publish.
Edits, swaps, sequencing, then load to schedule.
First post publishes. The monthly cycle begins.
Where timelines slip: Phase 1 moves at the speed of your turnaround. Block 30 minutes per feedback round and we hold the 4-6 week window.
Founder and expert-led thought leadership is where it begins, and the layer that keeps compounding to category leadership. Find your stage, and we'll tell you what to lead with.
Message-market fit. First conversions.
Attribution proven. Scaling begins.
Demand gen for out-of-market buyers.
Multi-channel at scale. Predictable pipeline.
Optimized economics. Brand compounds.
Roughly: a first health-system reference sits at Validate, a repeatable clinical and commercial case at Ramp, active demand creation at Reach, multi-system or multi-service-line at Supply, and recognized clinical authority at Sustain. Enterprise health buyers typically won't engage before Ramp.
Start where your voice is, then climb when it's earning. The combo is where most teams end up, because organic tells you which message works before you pay to scale it.
The combo. Test the messaging organically, amplify the winners as thought-leader ads, then harvest the signals the motion throws off, organic engagement, website visitors, and ad engagement, and flow them into email and LinkedIn connect and message plays. Full-funnel value out of every post.
Run the combo →A consistent founder voice on LinkedIn, from your real POV.
Strategy, inputs and multi-format content, ready to amplify.
The full brand brain, powering sharp assets across every channel, organic and paid.
Brand Engine output volumes are a representative monthly scope and flex to your priorities.
Own the voice extraction process, skill architecture, setup, documentation and training. Run it internally for any number of executives or partners.
A second voice on the same infrastructure. Add a partner or practice lead.
We sit on both sides of the LinkedIn relationship. On the paid side, we're a certified LinkedIn Marketing Partner. On the organic side, LinkedIn named our founder Thought Leader of the Year at the 2026 Indie Agency Awards. Paid and organic aren't two teams, they're one engine, and LinkedIn recognizes both halves.
An agency partner on the ads side, with the platform access, betas and rep coverage that come with it.
Named by LinkedIn at the Indie Agency Awards. Not a self-declared title. The platform itself called it.



On stage at LinkedIn's Independent Agency Summits, New York
DemandSense composes five signal sources, from your CRM to your LinkedIn paid and organic engagement to the companies and people identified on your site, into one account-level view: who is engaging with your content, from what company, in what role, and how close they are to a decision. It's what turns authority into a named list your sales team can act on. No competitor connects these dots.
The only LinkedIn ads agency we recommend to our clients. You do that incredibly well.
Everyone else had to beat what I'd already seen from them in organic content. I let the agency lead and I've been thrilled.
You changed the LinkedIn ads game for so many businesses, as clients, or with the content you share for free.
A governed knowledge base loaded with your voice, positioning, proof, frameworks and ICP, run by five foundational documents. It knows your brand better than anyone and produces sharp, on-brand assets across every channel, organic and paid.
Typically 4 to 6 weeks across three phases: voice calibration, first batch, approve and launch. The timeline depends on your turnaround on the intake form, calibration feedback and Month 1 inputs.
Directly. We test messages organically, amplify the winners as thought-leader ads across LinkedIn, YouTube and Facebook, then harvest the signals: organic engagement, named website visitors and ad engagement. Those flow into email and LinkedIn connect and message plays that feed the whole funnel.
We establish a pre-cleared claim library with your reviewers before writing begins, so assets are drafted inside your boundaries instead of corrected afterward. Everything still goes through your review, and nothing publishes without it. What changes is that review becomes a check rather than a rewrite, which is what restores publishing velocity.
Your clinicians provide the substance in recorded interviews and sign off on every asset before it ships. We handle structure, writing and distribution. Nothing publishes that your clinical reviewer hasn't approved, which is what keeps it credible to the audience that matters most.
Yes. Health-and-wellness and medical-device companies selling into providers fit the same evidence-led, compliance-aware playbook, including the pre-cleared claim library and the wide clinical committee.
The team behind Lacework's 6X, published by LinkedIn, and named LinkedIn's Thought Leader of the Year for 2026.